SonoSite to Present at Two Investor Conferences In September -- Northwest Medical Device & Biotechnology Forum and UBS Global Li

SonoSite, Inc. (Nasdaq:SONO), the world leader in
hand-carried ultrasound, today announced that Mike Schuh, Chief
Financial Officer, and Anne Bugge, Vice President of Corporate
Affairs, will present at the Northwest Medical Device & Biotechnology
Investor Forum at 10:00 a.m. (ET) on Tuesday, September 20, 2005, at
the Harvard Club of New York City. The forum is hosted by Delafield
Hambrecht and WBBA.
   SonoSite also announced that Kevin M. Goodwin, President and CEO,
will present at the 2005 UBS Global Life Sciences Conference at 12:30
p.m. (ET) on Wednesday, September 28 at the Grand Hyatt Hotel in New
York City. Investors can access an audio-webcast of Mr. Goodwin's
presentation on SonoSite's website
http://www.sonosite.com/webcast.html. The webcast will be available
beginning September 28, 2005, until 3:30 p.m. (ET) October 29, 2005.

   About SonoSite

   SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in hand-carried ultrasound, with an installed base of more than
20,000 systems. The company, headquartered near Seattle, Washington,
is represented by seven subsidiaries and a global distribution network
in over 75 countries. Approximately half of the company's revenues are
generated from international markets. SonoSite's small, lightweight
systems are expanding the use of ultrasound across the clinical
spectrum by cost-effectively bringing high performance ultrasound to
the point of patient care. The company employs approximately 450
people worldwide.